作者: L. Dufrechou , M. Nin , L. Curi , P. Larre Borges , M. Martínez Asuaga
DOI: 10.1016/J.TRANSPROCEED.2014.07.012
关键词:
摘要: Uruguay, with a total population of 3,345,000 inhabitants, is the Latin American country second highest number renal replacement therapies. Long-term immunosuppressant therapy essential for graft survival but results in reduced immunosurveillance, leading to an increased risk complications. A variety dermatological manifestations and large increase nonmelanoma skin cancers have been reported this population. The purpose study was evaluate frequency clinical spectrum cutaneous renopancreatic recipients 2 reference centers Uruguay. Two hundred six or between 21 77 years old were evaluated September 2009 2011. 206 dermatoses observed; 60% patients had at least 1 manifestation. most frequent side effects due immunosuppressive treatment (40.6%), followed by infections (26.1%), miscellaneous causes (18.9%), malignant premalignant lesions (14.4%). Transplant represent high-risk Physicians transplant units should be aware importance screening order promote early detection cancer.